戻る Agenda
Seamlessly Evolving Global Clinical Trial Liaison Field Medical Resources to Classic MSLs from Phase 3 to Launch
Session Chair(s)
Beth Price
Vice President
The Medical Affairs Company, United States
Panel experts share case studies and best practices to seamlessly evolve Clinical Trial Liaisons (CTLs) into classic MSL roles, efficiently leveraging company resources in support of global product launches. Variable workforce models to be discussed.
Learning Objective : Discuss how emerging biopharmaceutical companies seamlessly evolve their global Clinical Trial Liaisons (CTLs) into classic Medical Science Liaisons, from Phase 3 to the launch phase; Discuss best practices for deploying these global CTL teams, specifically highlighting workforce models utilized and the hiring, training, management and data documentation systems utilized.
Speaker(s)
Seamlessly Evolving Global Clinical Trial Liaison Resources to Classic MSLs from Early Phase to Launch
Lisa M. Burke, BSN, PHD, MBA, RN
Rhythm, United States
Senior Director, Field Medical
Site Engagement is a Team Sport
Kate Bradford, PHD
Arena Pharmaceuticals, Switzerland
Head of International Field Based Medicine